From the Pharmacy Counter to the National Table
Compounding pharmacy is under intense regulatory pressure right now. We refuse to sit on the sidelines. Revelation connects the daily realities of local practices to the national rooms where policy is made.
We push for regulation that makes practical sense.
Compounding pharmacy needs oversight. Patients and providers deserve confidence in what is being dispensed. Too often, however, regulation gets shaped without meaningful input from the field. The result is a wave of rules that restrict patient options without actually improving safety. We push for informed, practical policies that keep patients protected while giving providers room to do their jobs well.
Licensed and active in all 50 states.
With licensure in all 50 states between our network of pharmacies, regulations and laws are at the forefront of what we do. This landscape is ever-changing. Because our footprint spans the entire country, we serve as a vital connector. We link local pharmacists, independent providers, and national advocacy groups to build a unified front that protects compounding access for everyone.
State licensures
Proactive relationships across the country.
Compounding pharmacy is primarily regulated by State Boards of Pharmacy, along with policy from the FDA.
Our Team
- Attends State Board of Pharmacy meetings
- Builds and maintains working relationships with State Boards of Pharmacy members, FDA officials, and regulatory staff nationwide
- Tracks and advises on proposed rule or policy changes
- Coordinates company responses to proposed FDA guidance documents and state regulatory initiatives
- Attends FDA listening sessions and information meetings
Protecting patient options at the root.
The policy from regulatory bodies often stems from legislative changes, whether it's a new bill or amendments to existing law.
Our Team
- Meets regularly with Members of Congress, congressional staff, state legislators, and executive branch officials to successfully advance policies that protect patient access to compounded medications.
- Develops trusted relationships with policymakers and regulatory leaders across multiple states.
- Hosts pharmacy tours for legislators and government officials to demonstrate sterile and non-sterile compounding operations and their impact on patient care.
- Monitors legislation in all 50 states affecting pharmacy practice, compounding, reimbursement, and patient care.
- Drafts legislative language, testimony, policy briefs, and regulatory comments on behalf of the company and industry partners.
- Provides oral and written testimony before legislative committees and regulatory agencies.
- Coordinates grassroots advocacy efforts involving pharmacists, providers, and patients to ensure policymakers hear directly from those impacted.
- Collaborates with national trade associations and coalition partners to develop unified legislative strategies.
A trusted resource where it counts.
Revelation is widely recognized as a trusted resource for policymakers, regulators, and industry stakeholders on critical pharmacy compounding issues. We provide steady, strategic guidance on emerging legislative and regulatory developments affecting pharmacies nationwide. This eagle-eye vantage point helps our partners identify and address policy challenges before they impact patient care and pharmacy operations. By successfully bridging regulatory, legislative, and operational perspectives, we help develop practical policy solutions that hold up under real-world scrutiny.
Leading from inside the organizations that shape compounding policy.
Our team plays an active leadership role in the organizations shaping the future of pharmacy compounding. Through national associations, regulatory committees, and legislative advocacy, we help advance policies that protect therapeutic options and support high-quality compounding practice.
Alliance for Pharmacy Compounding
- Revelation Pharma is a 2026 Gold Corporate Patron of APC.
- Our Government Affairs Manager, Katie Johnston, serves on the Board of Directors and Vice Chairs the State Legislative & Regulatory Committee.
- Our Director of Government Affairs, David Rochefort, was the 2024 recipient of the Malmberg Award.
- We maintain annual attendance at Compounders on Capitol Hill.
- Our team participates in APC advocacy initiatives before Congress, FDA, and State Boards of Pharmacy.
- We help shape APC policy positions and state advocacy priorities affecting compounding pharmacies nationwide.
Outsourcing Facility Association
- We serve on the OFA State Policy Committee, contributing to national policy priorities for outsourcing facilities.
- Our team participates in OFA’s annual Legislative Seminar in Washington, D.C., meeting with Members of Congress and congressional staff.
- We collaborate with other outsourcing facilities to develop coordinated state and federal advocacy strategies.
- We assist in evaluating proposed state legislation affecting outsourcing facilities and sterile compounding.
- Our team supports development of model legislative and regulatory approaches promoting patient access and drug quality.
Broader Industry Participation
In addition to the two main associations that represent compounding, our team also actively participates in the National Association of Boards of Pharmacy, State Pharmacy Associations, the American Society of Pharmacy Law, retail pharmacy coalitions, and state legislative associations.
Meet the Regulatory & Government Affairs Team
Anthony Grzib
VP, Regulatory Affairs
David Rochefort
Director of Government Affairs
2024 APC Malmberg Award Recipient
Katie Johnston
APC Board of Directors